Clinical and microbiological efficacy of continuous versus intermittent administration of vancomycin in critical care patients

被引：1
|
作者：
M Štepán
I Chytra
P Pelnar
T Bergerová
E Kasal
A Zidkova
R Pradl
机构：
[1] University Hospital,
来源：
Critical Care | / 13卷 / Suppl 1期
关键词：
Vancomycin; Continuous Infusion; Sequential Organ Failure Assessment; Sequential Organ Failure Assessment Score; White Blood Count;
D O I：
10.1186/cc7470
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical and Microbiological Efficacy of Continuous Versus Intermittent Administration of Meropenem in Critically III Patients
    Chytra, I.
    Stepan, M.
    Bergerova, T.
    Kasal, E.
    Pelnar, P.
    Pradl, R.
    Zidkova, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E404 - E404
  • [2] Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
    Nicolau, DP
    McNabb, J
    Lacy, MK
    Quintiliani, R
    Nightingale, CH
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (06) : 497 - 504
  • [3] Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
    Maluangnon, Chailat
    Tongyoo, Surat
    Permpikul, Chairat
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 7751 - 7760
  • [4] Comparison of intermittent versus continuous-infusion vancomycin for treating severe patients in intensive care units
    Yamada, Carolina Hikari
    Telles, Joao Paulo
    Oliveira, Dayana dos Santos
    Cieslinski, Juliette
    Tasca Ribeiro, Victoria Stadler
    Gasparetto, Juliano
    Tuon, Felipe Francisco
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2020, 24 (04): : 356 - 359
  • [5] Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
    Chytra, Ivan
    Stepan, Martin
    Benes, Jan
    Pelnar, Petr
    Zidkova, Alexandra
    Bergerova, Tamara
    Pradl, Richard
    Kasal, Eduard
    CRITICAL CARE, 2012, 16 (03):
  • [6] Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
    Ivan Chytra
    Martin Stepan
    Jan Benes
    Petr Pelnar
    Alexandra Zidkova
    Tamara Bergerova
    Richard Pradl
    Eduard Kasal
    Critical Care, 16
  • [7] Comparative efficacy and prognostic impact of continuous versus intermittent hydrocortisone administration in septic shock patients
    Li Jin
    Zhenglei Li
    Jun Qian
    Wenjie Liao
    Feng Xu
    Scientific Reports, 15 (1)
  • [8] Enteral nutrition in critical patients; should the administration be continuous or intermittent?
    Tavares de Araujo, Viviane Maeve
    Gomes, Paulo Cesar
    Caporossi, Cervantes
    NUTRICION HOSPITALARIA, 2014, 29 (03) : 563 - 567
  • [9] Continuous versus intermittent meropenem administration in critically ill patients
    Thalhammer, F
    Traunmüller, F
    Hollenstein, UM
    Locker, GJ
    Staudinger, T
    Burgmann, H
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A139 - A139
  • [10] Continuous Versus Intermittent Administration of Meropenem in Critically Ill Patients
    Launay, Manon
    Perinel-Ragey, Sophie
    Thiery, Guillaume
    THERAPEUTIC DRUG MONITORING, 2024, 46 (05) : 692 - 693
12345